Daphne Quimi serves on the boards of Amylyx Pharmaceuticals (NASDAQ: AMLX) and Century Therapeutics (NASDAQ: IPSC). She has experience with acquisitions, CEO transitions, and major restructurings. Quimi is the Audit Chair for both companies.

Her extensive experience in financial management and strategic leadership makes her well-suited to support Chiesi's growth in the United States. Her expertise in corporate governance will be invaluable as Chiesi expands its presence in this critical market.

Quimi started her career as an auditor at KPMG between 1988 and 1991. From 1991 to 2004 she held several positions at Johnson & Johnson, including Project Manager in Financial Analysis, Manager of Worldwide Finance Procedures, and Director of Consolidations and External Reporting.

She held the role of Director of Financial Reporting at Bristol-Myers Squibb between 2005 and 2007, as well as taking up the role of Regional Controller, Sarbanes Oxley Compliance, Global Finance at Avon Products between 2004 and 2005.

Between 2007 and 2024, Quimi worked at Amicus Therapeutics. She started as a Director, External Reporting and Technical Accounting, later taking various roles as a controller. She then became Senior Vice President, Administration and Operations. Following this, she became the Chief Financial Officer between 2019 and 2023, before retiring from Amicus in 2024.

Quimi holds a BS in Accounting from Monmouth University, USA, which she received in 1988. She later earned a CPA, in New Jersey, USA. She concluded her studies with an MBA in Finance and International Business from New York University, USA in 1999. She is a US citizen.